Prostate cancer is characterized by elevated de novo synthesis of fatty acid and overexpression of key fatty acid synthesis enzymes such as acetyl-CoA carboxylase (ACC) and fatty acid synthase (FASN). This evidence concerns the gene FASN and prostate carcinoma.